Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
PRESS RELEASES
Aridis Pharmaceuticals To Present At The ROTH Capital Partners 2020 MedTech Innovation Forum On A COVID-19 Panel
By PR Newswire
Oct 27, 2020 5:30 AM EDT
PRESS RELEASES
Aridis Pharmaceuticals Reports Positive Preclinical Efficacy Data Of A Highly Effective Inhaled Treatment Supporting A Proposed Self-Administered Therapy For COVID-19 Patients
By PR Newswire
Oct 19, 2020 8:30 AM EDT
PRESS RELEASES
Aridis Pharmaceuticals Announces $8.5 Million Registered Direct Offering
By PR Newswire
Oct 14, 2020 5:30 AM EDT
PRESS RELEASES
Aridis Announces Agreement With The FDA On Updated Phase 2 Clinical Trial Design For AR-501
By PR Newswire
Sep 8, 2020 5:30 AM EDT
PRESS RELEASES
Aridis Pharmaceuticals To Present At Upcoming Investor Conferences
By PR Newswire
Sep 4, 2020 1:32 PM EDT
PRESS RELEASES
Aridis Pharmaceuticals To Participate In Cantor Fitzgerald Virtual Symposium: Winning Ways To Treat Infections And COVID-19
By PR Newswire
Jun 26, 2020 5:30 AM EDT
PRESS RELEASES
Aridis Reports AR-501 Clinical Data: Positive Safety Data In Healthy Subjects Of A Phase 1/2a Clinical Trial
By PR Newswire
Jun 22, 2020 5:30 AM EDT
PRESS RELEASES
Aridis Pharmaceuticals To Discuss APEX™ In Virtual Fireside Chat Hosted By Cantor Fitzgerald On June 25th
By PR Newswire
Jun 18, 2020 5:30 AM EDT
PRESS RELEASES
Aridis Pharmaceuticals Appoints Dr. Hasan Jafri As Chief Medical Officer
By PR Newswire
Jun 15, 2020 5:30 AM EDT
PRESS RELEASES
Aridis Pharmaceuticals Enrolls Its First COVID-19 Patient In Ongoing Phase 3 AR-301 Clinical Trial In Ventilator Associated Pneumonia (VAP)
By PR Newswire
May 4, 2020 5:30 AM EDT
PRESS RELEASES
Aridis Pharmaceuticals To Participate In Maxim Group's Infectious Disease Virtual Conference
By PR Newswire
Apr 29, 2020 5:30 AM EDT
PRESS RELEASES
Aridis Pharmaceuticals To Postpone Investor Day Due To Coronavirus Concerns
By PR Newswire
Mar 6, 2020 4:05 PM EST
PRESS RELEASES
Aridis Pharmaceuticals To Present At The 32nd Annual ROTH Conference
By PR Newswire
Mar 5, 2020 5:30 AM EST
PRESS RELEASES
Aridis Pharmaceuticals Provides Update On Investor Day Featuring Key Opinion Leader Panels On Cystic Fibrosis And Pneumonia
By PR Newswire
Mar 4, 2020 5:30 AM EST
PRESS RELEASES
Aridis Pharmaceuticals To Host Investor Day Showcasing APEX™ Technology Platform And Key Opinion Leader Panels On Cystic Fibrosis And Pneumonia
By PR Newswire
Feb 18, 2020 5:30 AM EST
PRESS RELEASES
Aridis Pharmaceuticals Presents APEX™ Antibody Discovery And Production Platform Technology At The 19th Annual CHI PepTalk Conference
By PR Newswire
Jan 28, 2020 2:56 PM EST
